Advanced Proteome Therapeutics Corporation (APTCF) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Biotecnología industria. La empresa tiene su sede en Burnaby, BC, Canada. El CEO actual es Benjamin Krantz.
APTCF tiene fecha de IPO 2009-07-10, cotiza en el Other OTC, una capitalización de mercado de $149.63K.
Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. The company develops and commercializes a platform for the chemical modification of protein therapeutics. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and immunomodulation. The company is headquartered in Burnaby, Canada.
